Japan, Nov. 7 -- PRECISION BIOLOGICS INC has got intellectual property rights for 'MONOCLONAL ANTIBODY NEO-201 FOR TREATMENT OF HUMAN CARCINOMAS.' Other related details are as follows:
Application Number: JP,2023-181486
Category (FI): A61P1/18,A61K38/20,A61P43/00,121,C12N15/13,A61K45/00,C07K16/30,A61P1/00,A61K47/50,A61K39/395@T,A61P37/04,A61P43/00,105,A61P35/00,A61P13/00,A61P11/00
Stage: Grant (IP right document published.)
Filing Date: Oct. 20, 2023
Publication Date: Jan. 23, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....